bovine mastitis market

Bovine Mastitis Market is Estimated to Witness High Growth Owing to Rising Prevalence of Mastitis in Dairy Cows

by

The bovine mastitis market is estimated to be valued at US$ 1497.52 Mn in 2023 and is expected to exhibit a CAGR of 5.2% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
Bovine mastitis is an inflammatory infection of the mammary gland usually caused by bacterial infections in dairy cows. The major products used in the treatment and prevention of bovine mastitis include antibiotics, pleural flushes, teat dip solutions, and vaccines. These products are used to prevent new intramammary infections and treat existing infections in dairy cows.

Market Dynamics:
Rising prevalence of mastitis in dairy cows is expected to drive the growth of the bovine mastitis market over the forecast period. According to the Food and Agriculture Organization of the United Nations, mastitis affects approximately 30% of the dairy cow population worldwide each year. Mastitis imposes huge economic losses on dairy farms due to reduced milk production, increased treatment costs, and discarded milk. Moreover, increasing adoption of advanced veterinary healthcare products by dairy farmers is also expected to support the market growth during the forecast period. In 2018, the National Animal Health Monitoring System in the United States reported that over 50% of the dairy operations used at least one type of mastitis management practice such as culturing of clinical mastitis cases, using a teat dip, and culling chronically infected cows.

The market is expected to gain significant growth opportunities due to increasing livestock population and rising demand for animal protein globally. However, stringent regulations associated with the use of veterinary drugs may hamper market growth over the forecast period.

SWOT Analysis

Strength: The Bovine Mastitis Market has strong growth potential due to the rising dairy production globally. Rapid urbanization is spurring the demand for dairy products. Furthermore, technological advancements are helping farmers address mastitis issues more efficiently.

Weakness: High treatment cost of mastitis hampers its mass adoption. Lack of awareness among farmers regarding mastitis prevention and management techniques restricts the market growth.

Opportunity: Growing dairy exports from developing nations present lucrative opportunities. Furthermore, development of advanced therapies provides new avenues.

Threats: Trade wars and political uncertainty pose challenges. Stringent regulations for antibiotic residues in milk also threaten market revenues.

Key Takeaways:

The global bovine mastitis market is expected to witness high growth, exhibiting CAGR of 5.2% over the forecast period, due to increasing milk consumption globally. Rising per capita dairy consumption backed by changing consumer dietary patterns drives the market.

Regional analysis: North America dominates the bovine mastitis market accounting for over 30% revenue share in 2023. This is attributed to well-established dairy sector and stringent dairy farming regulatory framework in the region. Asia Pacific exhibits highest growth fueled by rapidly developing dairy sector in China and India.

Key players operating in the bovine mastitis market are Zoetis, Merck & Co., Inc., Boehringer Ingelheim International GmbH, Bayer AG, Elanco, Ceva, West Way Health, Norbrook, DeLaval, ImmuCell Corporation, Advanced Animal Diagnostics, and Nimrod Veterinary Products Ltd. Zoetis leads the market with wide product portfolio for mastitis therapeutics and diagnostics. Other players compete on parameters of pricing, innovation and service quality.

*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it